arrow
J

Jeong Eon Lee

Samsung Medical Center
H指数:55
被引数:1.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Refined risk stratification in residual triple-negative breast cancer after neoadjuvant therapy using residual cancer burden class and lymphovascular invasion

新辅助治疗后残余三阴性乳腺癌的优化风险分层:基于残余肿瘤负荷分级和淋巴血管侵犯

2026-02-050
OAAI
Correlation Between Margin Status and Ipsilateral Breast Tumor Recurrence in Patients With Breast Cancer Undergoing Breast-Conserving Surgery With Whole-Breast Radiation Therapy

乳腺癌患者行保乳手术联合全乳腺放射治疗后切缘状态与同侧乳腺肿瘤复发的关系

2026-02-010
OA
Alteration in estrogen receptor status in metachronous contralateral breast cancer among unilateral early breast cancer patients with BRCA 1/2 mutations

单侧早期乳腺癌患者中,携带BRCA1/2突变者发生异时性对侧乳腺癌时雌激素受体状态的改变

2025-12-030
PRE
Whole-genome landscapes of 1,364 breast cancers

1,364例乳腺癌的全基因组景观

Nature
IF48.5
2025-12-030
OAAI
Corrigendum to “Hormonal factors predictive of fertility in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy in POSITIVE trial” [The Breast 83 (2025) 104547]

勘误:“Hormonal factors predictive of fertility in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy in POSITIVE trial” [The Breast 83 (2025) 104547]

2025-09-220
PREAI
Re-evaluating the necessity of removing residual calcifications detected after surgery in HR-/HER2+ breast cancer with pathologic complete response

重新评估在HR-/HER2+乳腺癌患者病理完全缓解后,术后检测到的残余钙化灶去除的必要性

2025-09-220
PREAI
Hormonal factors predictive of fertility in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy in POSITIVE trial

POSITIVE试验中,预测乳腺癌患者为尝试生育而中断辅助内分泌治疗时生育力的激素因素

2025-07-260
OAAI
Potential for omitting sentinel lymph node biopsy in patients with human epidermal growth factor receptor 2-positive or triple negative breast cancer with non-breast pCR after neoadjuvant chemotherapy

在完成新辅助化疗后,达到非乳腺病理完全缓解(pCR)的HER2阳性或三阴性乳腺癌患者中,省略哨兵淋巴结活检的潜力。

2025-07-150
PRE
Spatial and genomic profiling of residual breast cancer after neoadjuvant chemotherapy unveil divergent fates for each breast cancer subtype

新辅助化疗后残余乳腺癌的空间和基因组分析揭示了不同乳腺癌亚型的不同结局。

2025-06-060
OA
Outcomes in Nonmetastatic Hormone Receptor-Positive HER2-Negative Pure Mucinous Breast Cancer: A Multicenter Cohort Study
2024-06-010
OA